S-1 · resale registration
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 58 of OnKure Therapeutics, Inc.'s SEC filings and found 1 warrant series, 2 convertibles, 1 ATM program, 3 shelf registrations, 1 S-1 registration and 1 completed offering on file for OKUR. The latest dilution event on file is ATM sales on Aug 4, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 91 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 4, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Proposed maximum
Shares registered
Issued 2026
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2025
Total capacity
Sold to date
Issued 2025
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z